Edwards Lifesciences (EW) Total Non-Current Liabilities (2009 - 2026)
Edwards Lifesciences (EW) posted quarterly Total Non-Current Liabilities of $2.6 billion for Q1 2026, up 6.87% year-over-year from $2.5 billion in Q1 2025, and down 11.82% quarter-over-quarter from $3.0 billion in Q4 2025.
Edwards Lifesciences (EW) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends
Edwards Lifesciences' Total Non-Current Liabilities history runs 18 years deep, the most recent figure standing at $2.6 billion for Q1 2026.
- In Q1 2026, Total Non-Current Liabilities rose 6.87% year-over-year to $2.6 billion; the TTM figure through Mar 2026 stood at $2.6 billion (up 6.87% YoY), while the FY2025 annual figure was $3.0 billion, up 14.44% from the prior year.
- Total Non-Current Liabilities for Q1 2026 stood at $2.6 billion, down from $3.0 billion in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $3.0 billion in Q3 2024, with the low at $2.2 billion in Q2 2022.
- The 5-year median for Total Non-Current Liabilities is $2.4 billion (2023), against an average of $2.5 billion.
- The sharpest annual moves came in 2022 and 2024: Total Non-Current Liabilities tumbled 70.48% in 2022, then rose 25.41% in 2024.
- Edwards Lifesciences' Total Non-Current Liabilities stood at $2.3 billion in 2022, then advanced by 5.48% to $2.4 billion in 2023, then advanced by 9.47% to $2.6 billion in 2024, then rose by 14.44% to $3.0 billion in 2025, then fell by 11.82% to $2.6 billion in 2026.
- Business Quant data shows EW's Total Non-Current Liabilities at $2.6 billion in Q1 2026, $3.0 billion in Q4 2025, and $2.7 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Zimmer Biomet Holdings | 19.04 Bn | 18.63 Bn | 1.54 Bn | 9.53 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.57 Bn |
| Mar 31, 2026 | 2.64 Bn |
| Dec 31, 2025 | 3.00 Bn |
| Sep 30, 2025 | 2.70 Bn |
| Jun 30, 2025 | 2.50 Bn |
| Mar 31, 2025 | 2.47 Bn |
| Dec 31, 2024 | 2.62 Bn |
| Sep 30, 2024 | 3.01 Bn |
| Jun 30, 2024 | 2.25 Bn |
| Mar 31, 2024 | 2.21 Bn |
| Dec 31, 2023 | 2.39 Bn |
| Sep 30, 2023 | 2.40 Bn |
| Jun 30, 2023 | 2.31 Bn |
| Mar 31, 2023 | 2.31 Bn |
| Dec 31, 2022 | 2.27 Bn |
| Sep 30, 2022 | 2.20 Bn |
| Jun 30, 2022 | 2.20 Bn |
| Mar 31, 2022 | 2.30 Bn |
| Dec 31, 2021 | 2.48 Bn |
| Sep 30, 2021 | 2.34 Bn |